Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer Research

• Publication date

  2002-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11980634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet-derived Growth Factor C (PDGF-C), a Novel Growth Factor That Binds to PDGF α and β Receptor*

  2001cited by this paper
• Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor.

  2001cited by this paper
• PDGF-D, a new protease-activated growth factor

  2001influential reference
• PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor

  2001cited by this paper
• PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.

  2001cited by this paper
• Identification of chromosomal loci associated with non‐P‐glycoprotein–mediated multidrug resistance to topoisomerase II inhibitor in lung adenocarcinoma cell line by comparative genomic hybridization

  2001cited by this paper
• PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.

  2000cited by this paper
• A novel gene derived from developing spinal cords, SCDGF, is a unique member of the PDGF/VEGF family

  2000cited by this paper
• PDGF-C is a new protease-activated ligand for the PDGF α-receptor

  2000cited by this paper
• Matrix metalloproteinases in tumor invasion

  2000cited by this paper
• Regions of genomic instability on 22q11 and 11q23 as the etiology for the recurrent constitutional t(11;22).

  2000cited by this paper
• Comparison of genetic changes in primary sarcomas and their pulmonary metastases

  1999cited by this paper
• Mechanism of action and in vivo role of platelet-derived growth factor.

  1999cited by this paper
• Fully human anti‐interleukin‐8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states

  1999cited by this paper
• Solution structure of the epidermal growth factor (EGF)-like module of human complement protease C1r, an atypical member of the EGF family.

  1998cited by this paper
• Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization.

  1997cited by this paper
• Jacobsen syndrome: report of a patient with severe eye anomalies, growth hormone deficiency, and hypothyroidism associated with deletion 11 (q23q25) and review of 52 cases.

  1996cited by this paper
• Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization.

  1996cited by this paper
• The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family.

  1995cited by this paper
• Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice

  1993cited by this paper
• Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

  1993cited by this paper
• Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro.

  1992cited by this paper
• Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes.

  1989cited by this paper
• A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity.

  1984cited by this paper
• In vivo identification of the transforming gene product of simian sarcoma virus.

  1982cited by this paper

• Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma.

  2023cites this paper
• PDGF-D−PDGFRβ signaling enhances IL-15–mediated human natural killer cell survival

  2022cites this paper
• Targeting Angiogenic Factors for the Treatment of Medulloblastoma

  2022cites this paper
• CD43 (sialophorin) is involved in the induction of extracellular matrix remodeling and angiogenesis by lung cancer cells

  2021cites this paper
• The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin

  2021cites this paper
• Killing the Invaders: NK Cell Impact in Tumors and Anti-Tumor Therapy

  2021cites this paper
• A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer

  2021cites this paper
• NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans

  2019cites this paper
• MCP-1/CCL2 Mediated by Autocrine Loop of PDGF-BB Promotes Invasion of Lung Cancer Cell by Recruitment of Macrophages Via CCL2–CCR2 Axis

  2019cites this paper
• Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression

  2017cites this paper
• Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.

  2017influential citation
• The PDGF/PDGFR pathway as a drug target.

  2017cites this paper
• Neuroendocrine Neoplasms of the Brain

  2016cites this paper
• Exploring the functional heterogeneity of the tumor microenvironment

  2016cites this paper
• PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway

  2016cites this paper
• Central Neurocytoma: A Review of Clinical Management and Histopathologic Features

  2016cites this paper
• Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development

  2016cites this paper
• PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.

  2016cites this paper
• Clinical significance of platelet derived growth factor-C and -D in gastric cancer

  2015cites this paper
• Overexpression of platelet-derived growth factor-D as a poor prognosticator in endometrial cancer.

  2014cites this paper
• The roles of platelet-derived growth factors and their receptors in brain radiation necrosis

  2014cites this paper
• Molecular mechanisms of acquired gemcitabine resistance in pancreatic cancer

  2014cites this paper
• Gene Variants in Angiogenesis and Lymphangiogenesis and Cutaneous Melanoma Progression

  2013cites this paper
• Emerging roles of PDGF-D in EMT progression during tumorigenesis.

  2013cites this paper
• Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis.

  2013cites this paper
• AKT primes snail‐induced EMT concomitantly with the collective migration of squamous cell carcinoma cells

  2013cites this paper
• Cediranib inhibits both the intraosseous growth of PDGF D‐Positive prostate cancer cells and the associated bone reaction

  2012cites this paper
• Down-regulation of platelet-derived growth factor-D expression blockades NF-κB pathway to inhibit cell proliferation and invasion as well as induce apoptosis in esophageal squamous cell carcinoma

  2012cites this paper
• PDGF-D Improves Drug Delivery and Efficacy via Vascular Normalization, But Promotes Lymphatic Metastasis by Activating CXCR4 in Breast Cancer

  2011cites this paper
• The molecular pathology of central neurocytomas.

  2011cites this paper
• RETRACTED ARTICLE: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways

  2011cites this paper
• Platelet-derived growth factor receptor alpha overexpression cooperates with ink4a/arf loss to promote gliomagenesis---roles of shp-2 and pi3k pathways

  2011cites this paper
• Retraction Note to: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways

  2011cites this paper
• Molecular Mechanisms of Central Nervous System Metastasis

  2010cites this paper
• Emerging roles of PDGF-D signaling pathway in tumor development and progression.

  2010cites this paper
• RNAi-mediated inhibition of PDGF-D leads to decreased cell growth, invasion and angiogenesis in the SGC-7901 gastric cancer xenograft model

  2010cites this paper
• Patients with IgA nephropathy exhibit high systemic PDGF-DD levels.

  2009influential citation
• The Role of Gangliosides in Renal Cell Carcinoma

  2009cites this paper
• The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth

  2009cites this paper
• PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns.

  2009cites this paper
• Histone Deacetylase-1 Is Enriched at the Platelet-derived Growth Factor-D Promoter in Response to Interleukin-1β and Forms a Cytokine-inducible Gene-silencing Complex with NF-κB p65 and Interferon Regulatory Factor-1*

  2009cites this paper
• Platelet-Derived Growth Factor-DD, a Novel Mediator of Smooth Muscle Cell Phenotypic Modulation, is Upregulated in Endothelial Cells Exposed to Atherosclerotic-Prone Flow Patterns Abbreviated Title: PDGF-DD is a Novel SMC Phenotypic Modulator

  2008cites this paper
• Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile

  2008cites this paper
• Association of platelet-derived growth factor-D gene polymorphism with ischemic stroke in a Chinese case–control study

  2008cites this paper
• Characterization of the AP-1 and NF-kappa B transcription factors in the U-87 astrocytoma cell line

  2008cites this paper
• Pro-fibrogenic potential of PDGF-D in liver fibrosis.

  2007cites this paper
• Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.

  2007cites this paper
• Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of notch-1 and nuclear factor-κB signaling

  2007cites this paper
• New approaches to the chemotherapy of glioblastoma: investigations on doxorubicin nanoparticles, inhibition of PDGF receptors and kinesin Eg5, with emphasis on confocal laser-scanning microscopy

  2006cites this paper
• Inducible platelet-derived growth factor D-chain expression by angiotensin II and hydrogen peroxide involves transcriptional regulation by Ets-1 and Sp1.

  2006cites this paper
• Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.

  2006cites this paper
• Targeted Therapy for Renal Cell Carcinoma: A New Therapeutic Paradigm

  2006influential citation
• Neurocytoma Is a Tumor of Adult Neuronal Progenitor Cells

  2006cites this paper
• Antitumor activity of imatinib mesylate in neuroblastoma xenografts.

  2005cites this paper
• Homology-Based Genomic Mining of Growth Factors Implicated in Neoplasia and Nephritides

  2005cites this paper
• Matrix metalloproteinase-2 contributes to cancer cell migration on collagen.

  2005cites this paper
• Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.

  2005cites this paper
• The plateled-derived growth factor level (PDGF) in Hodgkin's disease and non-Hodgkin's lymphoma and its relationship disease activation

  2005cites this paper
• Platelet-Derived Growth Factor D Is Activated by Urokinase Plasminogen Activator in Prostate Carcinoma Cells

  2005cites this paper
• Structural and functional specificities of PDGF‐C and PDGF‐D, the novel members of the platelet‐derived growth factors family

  2005cites this paper
• Increasing tumor uptake of anticancer drugs with imatinib.

  2004cites this paper
• A novel method of Multiplexed Competitive Antibody Binning for the characterization of monoclonal antibodies.

  2004cites this paper
• Biological activities of novel Platelet-derived growth factors, PDGF-C and PDGF-D

  2004cites this paper
• PDGFD, a novel member of the plateletderived growth factor family

  2004cites this paper
• PDGFD, a novel member of the plateletderived growth factor family

  2004cites this paper
• Factor D in Prostate Cancer Progression A Potential Oncogenic Activity of Platelet-Derived Growth Updated

  2004cites this paper
• A Potential Oncogenic Activity of Platelet-Derived Growth Factor D in Prostate Cancer Progression

  2004cites this paper
• PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis.

  2004cites this paper
• PDGF receptors as cancer drug targets.

  2003cites this paper
• Novel PDGF family members: PDGF-C and PDGF-D.

  2003cites this paper
• A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.

  2003cites this paper
• The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery.

  2003cites this paper
• Inhibition of PDGF receptor signaling in tumor stroma : effects on interstitial hypertension, drug uptake and therapeutic response.

  2002cites this paper
• Platelet-derived growth factor-B and -C and active α-receptors in medulloblastoma cells

  2002cites this paper
• Platelet-derived growth factor-B and -C and active alpha-receptors in medulloblastoma cells.

  2002cites this paper
• Paracrine and autocrine functions of PDGF in malignant disease.

  2002cites this paper
• Chinese Anti鄄 Cancer a Ssociation

  year unknowncites this paper